Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 7, 2005
Structure-activity studies on prolactin-releasing peptide (PrRP). Analogues of PrRP-(19-31)-peptideRobert G Boyle, Robert Downham, Tanmoy Ganguly, et al.Journal of Medicinal Chemistry|April 25, 2007
Identification of inhibitors of protein kinase B using fragment-based lead discoveryGordon Saxty, Steven J Woodhead, Valerio Berdini, et al.Journal of the American Chemical Society|September 14, 2007
Total synthesis of (+)-sarain AMichael H Becker, Peter Chua, Robert Downham, et al.Basic Research in Cardiology|May 21, 2021
Preclinical trial of a MAP4K4 inhibitor to reduce infarct size in the pig: does cardioprotection in human stem cell-derived myocytes predict success in large mammals?Maaike Te Lintel Hekkert, Gary Newton, Kathryn Chapman, et al.Journal of Medicinal Chemistry|June 9, 2017
1,2,4-Triazolo-[1,5-a]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding InteractionSaleh Ahmed, Andrew Ayscough, Greg R Barker, et al.Journal of Medicinal Chemistry|August 20, 2010
Fragment-based drug discovery applied to Hsp90. Discovery of two lead series with high ligand efficiencyChristopher W Murray, Maria G Carr, Owen Callaghan, et al.Journal of Medicinal Chemistry|July 29, 2010
Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug designAndrew J Woodhead, Hayley Angove, Maria G Carr, et al.Pageof 1